18FDG-PET imaging in canine lymphoma and cutaneous mast cell tumor

Veterinary Radiology and Ultrasound

Volumn 50, Issue 2, 2009, Pages 215-223

  LeBlanc, Amy K ^a   Jakoby, Bjoern W ^b,c,d   Townsend, David W ^b   Daniel, Gregory B ^e  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^c SIEMENS CORPORATE RESEARCH   (United States)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Cancer; Canine; Molecular imaging

Indexed keywords

CANIS FAMILIARIS;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CANCER STAGING; DOG; DOG DISEASE; LYMPHOMA; MASTOCYTOMA; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ANIMALS; DOG DISEASES; DOGS; FLUORODEOXYGLUCOSE F18; LYMPHOMA; MASTOCYTOMA, SKIN; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 61449224567     PISSN: 10588183     EISSN: 17408261     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2009.01520.x     Document Type: Article

References (29)

1. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology 2004 231 : 305 332.
2. 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol 2005 33 : 145 155.
3. Hicks RJ, MacManus MP, Seymour JF. Initial staging of lymphoma with positron emission tomography and computed tomography. Semin Nucl Med 2005 35 : 165 175.
4. Sachelarie I, Kerr K, Ghesani M, et al. Integrated PET/CT: evidence-based review of oncology indications. Oncology (Williston Park) 2005 19 : 481 490.
5. 18FDG. Semin Nucl Med 2002 32 : 6 12.
6. 18FDG) with positron emission tomography in the normal dog. Vet Radiol Ultrasound 2008 49 : 182 188.
7. 18F]fluoro-d-glucose by fungal-associated inflammation: the standardized uptake value is greater for lesions of blastomycosis than for lymphoma in dogs with naturally occurring disease. Mol Imaging Biol 2002 4 : 201 207.
8. 18F]Fluoro-d-Glucose By Fungal-Associated Inflammation: the differential uptake ratio for Blastomyces-associated lesions is as high as for lymphoma and higher than for Turpentine Abscesses in experimentally induced lesions in rats. Mol Imaging Biol 2002 4 : 193 200.
9. Matwichuk CL, Daniel GB, Bowman LA, et al. Fluorine-18 fluorodeoxyglucose accumulation in blastomyces dermatitidis-associated inflammation in a dog. Clin Positron Imaging 1999 2 : 217 221.
10. Withrow SJ. Why worry about cancer in pets? In : Withrow SJ, MacEwen EG (eds) : Small animal clinical oncology, 3rd ed. Philadelphia, PA : WB Saunders, 2001 : 1 4.
11. Lee J, Hughes C, Fine R, et al. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance. Cancer 1996 77 : 1892 1898.
12. 18F]-fluorodeoxyglucose positron emission tomography on the staging and management of patients with non-Hodgkin's lymphoma. Clin Lymphoma 2003 4 : 50 51.
13. Alavi A, Kung JW, Zhuang H. Implications of PET based molecular imaging on the current and future practice of medicine. Semin Nucl Med 2004 34 : 56 69.
14. Jerusalem G, Hustinix R, Beguin Y, et al. Evaluation of therapy for lymphoma. Semin Nucl Med 2005 35 : 186 196.
15. Sato AF, Solano M. Ultrasonographic findings in abdominal mast cell disease: a retrospective study of 19 patients. Vet Radiol Ultrasound 2004 45 : 51 57.
16. Jakoby BW, Townsend DW, LeBlanc AK, et al. A large field-of-view high resolution panel detector positron emission tomography scanner for imaging animals. Mol Imag Biol 2006 8 : 88.
17. Jakoby BW, Townsend DW, Sibomana M, et al. A large volume PET scanner for low dose applications. IEEE MIC Conference Record 2006 M14 M153.
18. National Electrical Manufacturers Association. NEMA standards publication NU 2-2001. Performance measurements of positron emission tomographs. Rosslin, VA : National Electrical Manufacturers Association.
19. Conti M, Bendriem B, Casey ME, et al. Performance of a high sensitivity PET scanner based on LSO panel detectors. IEEE Trans Nucl Sci 2006 53 : 1136 1142.
20. Panin VY, Hamill JJ, Michel C, et al. Iterative transmission reconstruction for collimated coincidence point sources in rotating PET systems. Nucl Sci Symp Conf Rec, IEEE 2002 3 : 1660 1664.
21. Kwee TC, Kwee RM, Nievelstein RAJ. Imaging in the staging of malignant lymphoma: a systematic review. Blood 2008 111 : 504 516.
22. Garrett LD, Thamn DH, Chun R, Dudley R, Vail DM. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Int Med 2002 16 : 704 709.
23. 18F-FDG PET studied in mice. J Nucl Med 2006 47 : 999 1006.
24. Shreve PD. Whole-body PET imaging methods. In : Valk PE, Bailey DL, Townsend DW, Maisey MN (eds) : Positron emission tomography: basic science and clinical practice, 1st ed. New York, NY : Springer, 2004 481 493.
25. Weber WA. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 2005 46 : 983 995.
26. Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose after first-line chemotherapy in non-Hodgkin's lymphoma: is FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 2001 19 : 414 419.
27. 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med 2004 34 : 122 133.
28. Ware WA, Hopper DL. Cardiac tumors in dogs: 1982-1995. J Vet Int Med 1999 13 : 95 103.
29. Sims CS, Tobias AH, Hayden DW, et al. Pericardial effusion due to primary cardiac lymphosarcoma in a dog. J Vet Int Med 2003 17 : 923 927.